The authors suggested that HMGA2 oncoprotein plays critical roles in the pathogenesis of AT/RT development and reconstitution of let-7 miRNA may provide a novel therapeutic strategy for the treatment of AT/RT patients. This evidence concerns the gene HMGA2 and ataxia telangiectasia.